✦ LIBER ✦

984 COST-EFFECTIVENESS OF HCV TREATMENT IN GENOTYPE 1 NAIVE PATIENTS IN 2012

✍ Scribed by C. Brouard; C. Pioche; S. Le Vu; E. Delarocque-Astagneau; C. Semaille; C. Larsen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost Effectiveness of Direct-Acting Anti

✍ Chan, Kee; Lai, Mai Ngan; Groessl, Erik J.; Hanchate, Amresh D.; Wong, John B.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 757 KB

PGI17 Cost-Effectiveness of Telaprevir W

✍ H. Ishida; S. Terai; I. Sakaida; Y. Inoue 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Should we await IFN-free regimens to tre

✍ Deuffic-Burban, Sylvie; Schwarzinger, Michaël; Obach, Dorothée; Mallet, Vincent; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 704 KB

Management of treatment-naïve chronic he

✍ Cortesi, P. A.; Ciaccio, A.; Rota, M.; Lim, J. K.; De Salvia, S.; Okolicsanyi, S 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

O85 SHOULD WE AWAIT INTERFERON-FREE REGI

✍ Deuffic-Burban, S.; Schwarzinger, M.; Obach, D.; Mallet, V.; Pol, S.; Pageaux, G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Optimizing therapy in treatment-naïve ge

✍ Eliana Z. Agudelo; Norah A. Terrault 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 294 KB